SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 82 filers reported holding SURFACE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,981 | -45.9% | 6,875 | -56.5% | 0.00% | – |
| Q1 2023 | $11,048 | +62.1% | 15,805 | +90.1% | 0.00% | – |
| Q4 2022 | $6,817 | -89.5% | 8,313 | -86.6% | 0.00% | – |
| Q3 2022 | $65,000 | -78.1% | 62,127 | -65.6% | 0.00% | – |
| Q2 2022 | $297,000 | +25.8% | 180,682 | +124.6% | 0.00% | – |
| Q1 2022 | $236,000 | -41.0% | 80,436 | -4.0% | 0.00% | – |
| Q4 2021 | $400,000 | +198.5% | 83,791 | +375.7% | 0.00% | – |
| Q3 2021 | $134,000 | +26.4% | 17,615 | +23.4% | 0.00% | – |
| Q2 2021 | $106,000 | +17.8% | 14,269 | +24.4% | 0.00% | – |
| Q1 2021 | $90,000 | +30.4% | 11,466 | +52.9% | 0.00% | – |
| Q4 2020 | $69,000 | +3350.0% | 7,500 | +480.9% | 0.00% | – |
| Q3 2019 | $2,000 | -83.3% | 1,291 | -47.7% | 0.00% | – |
| Q1 2019 | $12,000 | +33.3% | 2,470 | +20.9% | 0.00% | – |
| Q4 2018 | $9,000 | -90.2% | 2,043 | -75.7% | 0.00% | – |
| Q3 2018 | $92,000 | +283.3% | 8,395 | +466.5% | 0.00% | – |
| Q2 2018 | $24,000 | – | 1,482 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
| ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
| SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
| Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
| C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
| ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
| Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
| Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
| HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |